Article by Lithuanian scientists in the most prestigious magazine „Science“

2017-06-30

One of the most prestigious magazines „Science“ published an article „A cyclic oligonucleotide signaling pathway in Type III CRISPR-Cas systems“ by Lithuanian scientists Miglė Kazlauskienė, Georgij Kostiuk, Česlovas Venclovas, Gintautas Tamulaitis ir Virginijus Šikšnys from Vilnius University Life Science Center Institute of Biotechnology.

This is the first time for Lithuanian scientists to be recognized by the magazine which is hosting the most advanced and significant scientific ideas in the world. „Science“ publishes on average only 7% of all submissions. The very fact of publication proves once again that Lithuanian scientists are on the verge of the most advanced scientific discoveries of global importance and impact.

Prof. V. Šikšnys and the team have been working on CRISPR-Cas systems for a number of years. Type III CRISPR-Cas systems in prokaryotes provide immunity against invading nucleic acids through the coordinated degradation of transcriptionally-active DNA and its transcripts by the Csm effector complex.  

Scientific discovery has been recognized by international business community for its potential in transferring into technologies for further commercialization: Vilnius University and US company „DuPont Pioneer“ in May, 2017 announced about the patent registration in US.

We will meet these scientists at the bi-annual forum „Life Sciences Baltic 2018“ in Vilnius, an established and recognized location in world life science and business for trend-setters.

Save the date – September 26-27, 2018!

The article: http://science.sciencemag.org/content/early/2017/06/28/science.aao0100

E. Kurauskas foto.

Read further

Startup Fair participant Oxipit, a Startup that Uses AI to Diagnose Cancer, Won the First Offical Investment of LitBAN
Startup Fair participant Oxipit, a Startup that Uses AI to Diagnose Cancer, Won the First Offical Investment of LitBAN
2018-06-22

Lithuanian Business Angels Network (LitBAN), together with Co-Investment Fund “Koinvesticinis Fondas” and Startup Lithuania, after  Startup Fair. Growth 2018 announced the first official investment in a Lithuanian startup. A unique investment of 100K EUR will go to Oxipit, a startup developing innovative diagnostic tools that allow to recognize cancer and other pathologies in radiograms using AI.

Patient-specific solutions for personal healthcare: just press print
Patient-specific solutions for personal healthcare: just press print
2018-06-20

Many people who are eagerly waiting for the pain to go away with their new artificial hip, jaw, teeth or even limb can secure a higher quality of life with the help of 3D printing. The personalization of health care, less painful treatment and faster recovery are opened up by personalized prostheses and medical devices. A revolution of healthcare using 3D printing is already occurring in Lithuania.